Validation of the Lithuanian Version of the International Restless Legs Syndrome Study Group Rating Scale for Restless Legs Syndrome
- PMID: 40572716
- PMCID: PMC12195289
- DOI: 10.3390/medicina61061028
Validation of the Lithuanian Version of the International Restless Legs Syndrome Study Group Rating Scale for Restless Legs Syndrome
Abstract
Background and Objectives: According to the literature, Restless Legs Syndrome (RLS) often remains underdiagnosed, with only a small proportion of individuals experiencing symptoms receiving an official diagnosis, highlighting the need for effective screening and diagnostic tools. The International Restless Legs Syndrome Study Group Rating Scale (IRLS) is a widely used tool for assessing the severity of Restless Legs Syndrome (RLS). However, a validated Lithuanian version has not yet been established. This study aimed to validate the Lithuanian version of the IRLS and assess its reliability, diagnostic performance, and correlation with clinical and demographic factors. Materials and Methods: This retrospective study included 136 patients who completed the Lithuanian version of the IRLS and underwent polysomnographic and clinical evaluations at the Department of Neurology of the Lithuanian University of Health Sciences between 2018 and 2024. A total of 134 patients were analyzed: 66 with clinically confirmed RLS and 68 controls without sleep disorders. Statistical analysis included the Mann-Whitney U test, chi-squared tests, Receiver Operating Characteristics (ROC) curve analysis, multivariate logistic regression, and Akaike Information Criterion (AIC). Results: The Lithuanian IRLS demonstrated good diagnostic accuracy with an Area Under the Curve (AUC) value of 0.843 (95% CI: 0.782-0.904), with an optimal cut-off score of 7.50, resulting in high sensitivity (92.4%) and moderate specificity (66.2%). Multivariate regression identified higher IRLS scores (OR = 1.212, 95% CI: 1.084-1.356, p < 0.001) and a higher periodic limb movements of sleep arousal index (PLMSAI) (OR = 1.961, 95% CI: 1.036-3.712, p = 0.039) as significant independent predictors of RLS. After adjustments for age and sex, both IRLS scores and PLMSAI remained statistically significant predictors. Conclusions: the Lithuanian version of IRLS is a valid and reliable instrument for assessing RLS severity. Its diagnostic performance supports its use in clinical and research settings for identifying and monitoring RLS in Lithuanian population.
Keywords: international restless legs syndrome rating scale; periodic limb movement disorder; restless legs syndrome; screening tool; sleep disorders; validation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Iron for restless legs syndrome.Cochrane Database Syst Rev. 2012 May 16;5(5):CD007834. doi: 10.1002/14651858.CD007834.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2019 Jan 04;1:CD007834. doi: 10.1002/14651858.CD007834.pub3. PMID: 22592724 Free PMC article. Updated.
-
Association between serum GFAP, BDNF and NfL levels and clinical symptoms in restless legs syndrome: a case-control study.Sleep Med. 2025 Jul 17;134:106694. doi: 10.1016/j.sleep.2025.106694. Online ahead of print. Sleep Med. 2025. PMID: 40706400
-
Interventions for chronic kidney disease-associated restless legs syndrome.Cochrane Database Syst Rev. 2016 Nov 7;11(11):CD010690. doi: 10.1002/14651858.CD010690.pub2. Cochrane Database Syst Rev. 2016. PMID: 27819409 Free PMC article.
-
Transcutaneous electric nerve stimulation in restless leg syndrome with cirrhosis: a pilot study.Expert Rev Med Devices. 2025 Jul;22(7):757-765. doi: 10.1080/17434440.2025.2508872. Epub 2025 May 20. Expert Rev Med Devices. 2025. PMID: 40391712 Clinical Trial.
-
Opioids for restless legs syndrome.Cochrane Database Syst Rev. 2016 Jun 29;2016(6):CD006941. doi: 10.1002/14651858.CD006941.pub2. Cochrane Database Syst Rev. 2016. PMID: 27355187 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical